HBW Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

States Could Take Bloom Off Growth Of CBD Supplement, Food Market

Executive Summary

State regulators are biggest threat to CBD-containing supplement and food marketers, say food and drug lawyers. Some states, not all, track federal laws with their regulations while others dig in their heels against sale and transport of products.
Advertisement

Related Content

Legalizing Marijuana Would Calm CBD Regulatory Storm – CV Sciences' MacKay
CBD Supplement Market Enforcement Based On FDA Concerns, Not Discretion
CBD Supplement Trademarks Must Wait For FDA's Dietary Ingredient Solution
Perrigo's Turnaround Tools: 'National Brand,' Novel NRTs, CBD And Natural Products, Sponsoring OTC Switches
Cosmetics Firms ‘Chomping At The Bit’ To Use CBD, But Do So At Own Peril, Attorney Says
FDA Clearing CBD As Dietary Ingredient? Legislation More Likely Than Rulemaking
It's Complicated: FDA Prohibits CBD In Supplements, Enforcement Priority On Disease Claims

Topics

Advertisement
UsernamePublicRestriction

Register

RS148791

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel